Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jupiter Neurosciences (JUNS) Return on Sales (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Return on Sales for 2 consecutive years, with 45.97% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 12222.0% to 45.97% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 135.43% through Dec 2025, up 11581.0% year-over-year, with the annual reading at 411.76% for FY2025, N/A changed from the prior year.
  • Return on Sales for Q4 2025 was 45.97% at Jupiter Neurosciences, down from 1917.88% in the prior quarter.
  • The five-year high for Return on Sales was 1984.99% in Q2 2025, with the low at 76.25% in Q4 2024.